These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27922750)

  • 1. Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions.
    van der Eijk AA; Tintu AN; Hays JP
    Future Microbiol; 2017 Jan; 12():51-58. PubMed ID: 27922750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential of Next-generation POCT in Infectious Disease Rapid Test].
    Shimetani N
    Med Mycol J; 2017; 58(3):J91-J94. PubMed ID: 28855485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Applications of Point-of-Care Testing in Different Conditions.
    Sumita NM; Ferreira CES; Martino MDV; Franca CN; Faulhaber ACL; Scartezini M; Pinho JRR; Dias CM; Cesar KR; Pariz VM; Guerra JCC; Barbosa IV; Faulhaber MHW; Batista MC; Andriolo A; Mendes ME; Machado AMO; Colombini MP; Slhessarenko N; Shcolnik W; Khawali C; Campana GA; Berlitz F; Galoro CA
    Clin Lab; 2018 Jul; 64(7):1105-1112. PubMed ID: 30146832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation package.
    Hays JP; Mitsakakis K; Luz S; van Belkum A; Becker K; van den Bruel A; Harbarth S; Rex JH; Simonsen GS; Werner G; Di Gregori V; Lüdke G; van Staa T; Moran-Gilad J; Bachmann TT;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1015-1022. PubMed ID: 30710202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The state of point-of-care testing: a European perspective.
    Larsson A; Greig-Pylypczuk R; Huisman A
    Ups J Med Sci; 2015 Mar; 120(1):1-10. PubMed ID: 25622619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Global Trends in the Use of Point-of-Care Testing Devices and Efforts toward Standardization.].
    Miyachi H
    Rinsho Byori; 2016 May; 64(4):437-441. PubMed ID: 29182814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-Care Testing: General Aspects.
    Ferreira CES; Guerra JCC; Slhessarenko N; Scartezini M; Franca CN; Colombini MP; Berlitz F; Machado AMO; Campana GA; Faulhaber ACL; Galoro CA; Dias CM; Shcolnik W; Martino MDV; Cesar KR; Sumita NM; Mendes ME; Faulhaber MHW; Pinho JRR; Barbosa IV; Batista MC; Khawali C; Pariz VM; Andriolo A
    Clin Lab; 2018 Jan; 64(1):1-9. PubMed ID: 29479878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study.
    Hocking L; George J; Broberg EK; Struelens MJ; Leitmeyer KC; Deshpande A; Parkinson S; Francombe J; Morley KI; de Carvalho Gomes H
    Front Public Health; 2021; 9():722943. PubMed ID: 34746078
    [No Abstract]   [Full Text] [Related]  

  • 9. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
    Jain S; Nehra M; Kumar R; Dilbaghi N; Hu T; Kumar S; Kaushik A; Li CZ
    Biosens Bioelectron; 2021 May; 179():113074. PubMed ID: 33596516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in the practical implementation of POCT: overcoming challenges.
    Wiencek J; Nichols J
    Expert Rev Mol Diagn; 2016; 16(4):415-22. PubMed ID: 26783053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.
    Weber NC; Klepser ME; Akers JM; Klepser DG; Adams AJ
    Expert Rev Mol Diagn; 2016; 16(2):253-64. PubMed ID: 26560318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of glucose point of care testing in three metropolitan hospitals.
    Sharp L; Farrance I; Greaves RF
    Pathology; 2016 Jan; 48(1):51-9. PubMed ID: 27020210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care testing governance in New Zealand through the lens of quality: an update on a national regulatory framework.
    Musaad SM; Herd GC
    N Z Med J; 2019 Jul; 132(1499):56-63. PubMed ID: 31352475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POCT Analysts' Perspective: Practices and Wants for Improvement.
    Westgard SA; Goldschmidt HMJ; Ehrmeyer SS
    J Appl Lab Med; 2020 May; 5(3):480-493. PubMed ID: 32445365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can point-of-care testing shorten hospitalization length of stay? An exploratory investigation of infectious agents using regression modelling.
    Gkika E; Psaroulaki A; Tselentis Y; Angelakis E; Kouikoglou VS
    Health Informatics J; 2019 Dec; 25(4):1606-1617. PubMed ID: 30179068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care Model Design for E-Health: Integration of Point-of-Care Testing at Dutch General Practices.
    Verhees B; van Kuijk K; Simonse L
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29267224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectiological Rapid Tests in Practices and at Home].
    Spinner CD; Müller MC; Lange B
    Dtsch Med Wochenschr; 2018 Feb; 143(3):157-160. PubMed ID: 29409084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Users Regard Operator Training as Critical for Successful POCT Applications.
    Bietenbeck A; Wüst K; Luppa PB
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Point-of-care-testing in general practice].
    Hopstaken RM; van Balen JA; Kusters R
    Ned Tijdschr Geneeskd; 2015; 159():A9475. PubMed ID: 26395570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of infectious diseases service consultation on diagnosis of infective endocarditis.
    Yamamoto S; Hosokawa N; Sogi M; Inakaku M; Imoto K; Ohji G; Doi A; Iwabuchi S; Iwata K
    Scand J Infect Dis; 2012 Apr; 44(4):270-5. PubMed ID: 22176644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.